Bile Compound Prevents Diabetes in Mice

A chemical prevalent in the bear gallbladder abates a cellular stress response and stalls the progression of type 1 diabetes in rodents.

kerry grens
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, TONY HISGETTIn people with type 1 diabetes, an incurable disease diagnosed early in life, the pancreas is deficient in producing insulin. There's been some idea that stress responses from the endoplasmic reticulum (ER) in pancreatic beta cells are involved, particularly the unfolded protein response. In Science Translational Medicine this week (November 13), scientists show that tamping down the ER stress response with a compound found in bear bile can slow the development of type 1 diabetes in mice.

“The study is exciting because it suggests that improving ER function before the onset of disease could reduce [type 1 diabetes] incidence,” said lead author Feyza Engin, a researcher at the Harvard School of Public Health, in a press release.

The compound, tauroursodeoxycholic acid (TUDCA), has been used for centuries in traditional Chinese medicine to treat a variety of ailments, and it was often sourced from the bile of bears. “The gallbladder of the bear was one of the most valuable voodoo medicines that people used, especially in China,” Gokhan Hotamisligil, a geneticist at Harvard University School of Public Health and a co-author of the study, told National Geographic. “It almost made the black bear extinct [in China].” Fortunately, if Hotamisligil's idea of using it ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • kerry grens

    Kerry Grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo